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Introduction
Doxorubicin (Dox) is one of the most potent broad spec-
trum antitumor anthracycline antibiotic, widely used 
to treat a variety of cancers, including severe leukemias, 
lymphomas, and solid tumors (Priestman, 2008). The 
clinical use of Dox is restricted because of its serious tox-
icity on various organs viz., heart, liver, lung, kidney, and 
testis (Lui et al., 1986; Ng et al., 2006; Injac & Strukelj, 2008). 
Doxorubicin administration can induce a wide variety 
of acute cardiotoxic effects including transient cardiac 
arrhythmia, nonspecific electrocardiographic abnormali-
ties, pericarditis, and acute heart failure (Billingham et al., 
1978). Although, the precise mechanism is unclear, pro-
duction of free radicals as a byproduct of its metabolism is 
considered to be the primary mechanism of Dox toxicity, 
consequently warranting some new approaches, such as 
the potential use of natural antioxidants, most commonly 
used and investigated compounds being vitamins (A, C, 
and E), coenzyme Q, flavonoids, polyphenols, herbal anti-
oxidants, selenium, and virgin olive oil (Quiles et al., 2002).
Ficus racemosa Linn. (syn. Ficus glomerata Roxb.) 
(Moraceae), commonly known as Gular, is widely distrib-
uted all over India, northern Australia, and other parts of 
Asia. In the Indian traditional system of medicine, all parts 
of this plant are considered important and have been 
extensively used in biliary disorders, dysentery, diabetes, 
diarrhea, and inflammatory conditions (Kirtikar & Basu, 
1975; Nadkarni et al., 1976). F. racemosa bark being rich 
source of polyphenolic compounds has shown to pos-
sess excellent antioxidant properties in terms of radical 
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Context: Ficus racemosa Linn. (Moraceae) bark is a rich source of phenolic compounds having diverse biological 
properties including antioxidant activity. The present study evaluated the cardioprotective activity of sequential 
acetone extract of Ficus racemosa bark against doxorubicin-induced cardiotoxicity in rats. 
Materials and methods: The extract was standardized by high-performance liquid chromatography (HPLC) and 
subjected to acute toxicological evaluation in mice. Cardiotoxicity was induced by administration of doxorubicin 
(10 mg kg−1 i.v.) to the extract pretreated rats (250 and 500 mg kg−1) and compared with that of Arjuna, a standard 
cardiotonic. Biochemical parameters included CK-MB, LDH, AST, ALT, troponin I, thiobarbituric acid reactive substances 
(TBARS), and glutathione. 
Results: The HPLC fingerprinting of the extract indicated the presence of bergenin (0.89%) and bergapten (0.07%). In an 
acute toxicity study, the extract at a dose of 2 g kg−1 did not cause any adverse changes and no mortality was observed. 
Administration of doxorubicin significantly increased (p ≤ 0.05) serum levels of creatine kinase, lactate dehydrogenase, aspartate 
aminotransferase, and alanine aminotransferase, which were decreased to an extent of 68, 63, 41, and 65%, respectively, in 
extract pretreated group (500 mg kg−1). Troponin I was undetected in control group, while it was found in serum of all the 
experimental groups. The extract pretreatment significantly decreased (p ≤ 0.05) TBARS and increased glutathione levels in 
serum and cardiac tissue. These observations were further substantiated by the histopathological studies. 
Conclusion: The acetone extract of F. racemosa bark possesses potential cardioprotective activity against doxorubicin-
induced cardiotoxicity in rats by scavenging free radicals generated by the administration of the drug.
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scavenging activity, reducing power and antilipidperoxi-
dative activity in rat liver homogenate (Ahmed & Urooj, 
2009a). Further, it has also exhibited significant TBARS 
lowering and glutathione restoration effect in strepto-
zotocin-induced diabetic rats (Ahmed & Urooj, 2009b). 
We have also reported F. racemosa stem bark to exhibit 
potential hepatoprotective effect against CCl
4
-induced 
hepatotoxicity in rats (Ahmed & Urooj, 2010).
In view of the above, since there are no reports on the 
cardioprotective activity of F. racemosa, the present study 
evaluated the cardioprotective activity of standardized 
extract of F. racemosa stem bark against doxorubicin-
induced cardiotoxicity in rats.
Materials and methods
Chemicals and reagents
Doxorubicin and 5,5-dithio(bis)nitro benzoic acid 
(DTNB) were purchased from Sigma Aldrich, Bangalore, 
India. Creatine kinase (CK-MB), lactate dehydrogenase 
(LDH), alanine aminotransferase (ALT), aspartate ami-
notransferase (AST), troponin I (Agappe Diagnostics, 
Ernakulam, India) assay kits, and Arjuna (Himalaya 
Healthcare, Bangalore, India), a standard cardio tonic 
were used. All the other chemicals and reagents used in 
the study were of extra pure analytical grade.
Preparation of the extract and high-performance 
liquid chromatography fingerprinting
Ficus racemosa stem bark was collected from 
Mukkadahally, Chamarajanagar district of Karnataka, 
India during September 2007, and was subsequently iden-
tified by Dr. Shivprasad Hudeda, JSS Ayurvedic Medical 
College, Mysore; a voucher specimen (BOT-001/2008) 
was deposited at the herbarium of the Department of 
Studies in Botany, University of Mysore, Mysore, India. 
The bark was cut into small pieces, dried (50°C) and 
powdered, passed through a 60 mesh sieve (BS), and 
the powder was extracted sequentially with solvents 
of increasing polarity (petroleum ether − chloroform − 
acetone − methanol − water) in a Soxhlet apparatus for 
8 h each. Acetone extract (FRSACE) containing highest 
amount of phenolic compounds (Ahmed & Urooj, 2009a) 
was selected and analyzed by high-performance liquid 
chromatography (HPLC) (Shimadzu Corporation, Japan) 
using 1000 ppm solutions on a reverse phase packed 
column (RP C-18 column; Supleco, USA; 250 × 4.6 mm2; 
particle size 5 µm) using gradient elution with water and 
acetonitrile at a flow rate of 1.0 mL min−1 and run time of 
30 min, monitored by a PDA detector at 270 nm. Gradient 
composition (min, % acetonitrile): 0, 20%; 5, 40%; 8, 75%; 
12, 90%; 15, 95%; 25, 95%; 27, 20%; 30, 20% was used. The 
compounds were identified using external standards, 
wherein the standard solutions (1000 ppm) were repeat-
edly injected (n = 4) to confirm reproducibility of peak 
area and retention time. The relative standard deviation 
(RSD) values were less than 1.1% for peak areas and less 
than 0.5% for retention times.
Acute toxicity studies
Acute toxicity tests were carried out in Swiss albino mice 
of both the sexes weighing 20 ± 2 g according to OECD 
423 guidelines (OECD, 2001). The animals were divided 
into following two groups consisting of six animals each 
(three male and three female).
Group I (Control): normal mice received olive oil •	
(1 mL kg−1 p.o.)
Group II (FRSACE): received sequential acetone •	
extract (2 g kg−1 p.o.)
 The mice were housed in polyacrylic cages and main-
tained at 23 ± 2°C, 45–60% RH and 12 h photo period. 
The extracts were given in the form of suspension after 
homogenization with olive oil by gavage using a stom-
ach tube. They were provided with a standard pellet diet 
(Amrut feeds, Pune, India) and water ad libitum.
The animals were observed individually after dosing 
at least once during the first 30 min interval during the 
first 24 h, with special attention given during the first 4 h, 
and daily thereafter, for a total of 14 days. All observations 
were systematically recorded with individual records 
being maintained for each animal. The observations 
included changes in skin and fur, eyes and mucous mem-
branes, and also respiratory, circulatory, autonomic, 
and central nervous systems, and somatomotor activity, 
behavior pattern, and mortality. Attention was given to 
observations of tremors, convulsions, salivation, diar-
rhea, lethargy, sleep, and coma.
Cardioprotective activity
Healthy male Wistar rats between 8 and 9 weeks of age 
and weighing 140–160 g were divided into following five 
groups (n = 6).
Group I: Control group; received distilled water (1 mL •	
kg−1 BW, p.o.) for 9 days followed by sterile water for 
injection (1 mL kg−1 BW, i.v.) on 10th day.
Group II: Dox group; received distilled water (1 mL •	
kg−1 BW, p.o.) for 9 days followed by a single dose of 
Dox injection (10 mg kg−1 BW, i.v.) on the 10th day.
Group III: FR•	
250
 group; received FRSACE (250 mg kg−1 
BW, p.o.) for 9 days followed by a single dose of Dox 
injection (10 mg kg−1 BW, i.v.) on the 10th day.
Group IV: FR•	
500
 group; received FRSACE (500 mg kg−1 
BW, p.o.) for 9 days followed by a single dose of Dox 
injection (10 mg kg−1 BW, i.v.) on the 10th day.
Group V: AR•	
100
 group; received Arjuna (100 mg kg−1 
BW, p.o.) for 9 days followed by a single dose of Dox 
injection (10 mg kg−1 BW, i.v.) on the 10th day.
 The rats were housed in polyacrylic cages and maintained 
at 27 ± 2°C, 45–60% RH and 12 h photo period. The rats 
were provided with a standard pellet diet (Amrut feeds, 
Pune, India) and water ad libitum. All animal procedures 
have been approved by the Animal Ethical Committee of 
University of Mysore in accordance with animal experi-
mentation and care. After 48 h of the injection of either 
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Dox or vehicle, the animals were starved overnight (to 
minimize metabolic variations), euthanized and blood 
was collected by direct cardiac puncture and used for 
serum separation. The activities of CK-MB, LDH, ALT, 
AST, and troponin I were determined as markers of 
cardiotoxicity in serum. Heart was immediately excised 
and a portion was homogenized (1:5 w/v) in phosphate-
buffered saline (pH 7.4) for estimation of TBARS and glu-
tathione (GSH) as markers of oxidative stress according 
to the methods reported earlier (Ahmed & Urooj, 2009a), 
while the other portion was fixed in 10% formalin, dehy-
drated in graduated ethanol (50%–100%), cleared in 
xylene and embedded in paraffin. The sections (4–5 μm) 
were then examined with a photomicroscope (Leica DM 
LS2, Switzerland) after staining with hematoxylin and 
eosin (H–E) dye. The morphological changes included 
cell necrosis, mononuclear infiltration, vacuolation, and 
degenerative changes.
Statistical analysis
Data are presented as mean ± SD and analyzed by one-
way analysis of variance (ANOVA) followed by Tukey’s 
multiple comparisons test for significant differences 
using SPSS version 14.0 software (SPSS Inc., Chicago, IL, 
USA). The values were considered significant at p ≤ 0.05.
Results and discussion
Acute toxicity study
In the acute oral toxicity test, the extract (2 g kg−1) did 
not show any signs of toxicity such as behavioral, ANS/
CNS changes, dermatitis, scaling, and no mortality was 
observed during the 14-day observation. Based on these 
findings, according to the OECD 423 guidelines, an LD
50
 
value of >2000 mg kg−1 was deduced for the extract.
HPLC fingerprinting
The HPLC chromatogram of FRSACE was found to contain 
constituents eluting between 1.009 min and 13.481 min 
with major peaks at 2.746 and 3.587 min (Figure 1). The 
peak found at 3.587 min was identified as bergenin and 
a minor peak found at 13.481 min was identified as ber-
gapten (5-methoxy psoralen). The concentrations of ber-
genin and bergapten were 0.89% and 0.07%, respectively. 
Figure 1. HPLC chromatogram of sequential acetone extract. The HPLC chromatogram was separated on a RP-C18 column (250 × 4.6 mm2; 
5 µm) using gradient elution-water and acetonitrile at a total flow rate of 1.0 mL min−1; gradient composition (min,% acetonitrile): 0, 20%; 
5, 40%; 8, 75%; 12, 90%;15, 95%; 25, 95%; 27, 20%; 30, 20%. The chromatogram at 270 nm was analyzed and compared.
Table 1. Effect of FRSACE on key cardiac and hepatic enzymes in serum.
Group CK-MB (U L−1) LDH (U L−1) Troponin I AST (U L−1) ALT (U L−1)
Control 437a ± 29.5 601a ± 57.3 – 98a ± 11.5 53a ± 7.9
FR
250
1209c ± 42.9 1779c ± 88.7 + 283c ± 23.7 201c ± 18.9
FR
500
790b ± 44.3 903b ± 65.1 + 212b ± 15.3 124b ± 7.6
AR
100
1314d ± 47.7 1828d ± 79.9 + 274c ± 25.7 193c ± 15.7
DOX 2107e ± 83.9 2859e ± 88.2 + 357d ± 27.7 356d ± 23.1
aData expressed as mean ± SD of n = 6 rats (p ≤ 0.05); bFR
250
: FRSACE 250 mg kg−1, FR
500
: FRSACE 500 mg kg−1, AR
100
: arjuna 100 mg kg−1, 
Dox: doxorubicin; cValues carrying different superscripts a–e in columns differ significantly from each other (p ≤ 0.05).
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Veerapur et al. (2007) have earlier reported the presence 
of bergenin in the ethanol extract of F. racemosa bark.
Cardioprotective effect
Cardiotoxic compounds such as doxorubicin are 
known to cause elevation in CK-MB, LDH, and serum 
transaminases. The activities of LDH, CK-MB, AST, 
ALT, and the presence of troponin I in serum were 
determined as markers of cardiotoxicity (Table 1). As 
expected, doxorubicin administration induced severe 
cardiac damage as the activities of LDH and CK-MB 
were found to be significantly (p ≤ 0.001) elevated 
compared to control groups. Pretreatment with FR
250
, 
FR
500
, and AR
100
 significantly attenuated (p ≤ 0.01) the 
increase in their activities. The percentage reductions 
in LDH activity by FR
250
, FR
500
 and AR
100
 were 38, 68, 
and 36% respectively, while, the activity of CK-MB was 
decreased to an extent of 43, 63, and 38% by FR
250
, FR
500
, 
and AR
100
, respectively. Troponin I was undetected 
only in the serum of control, while it was found in all 
the experimental groups.
These findings are in good agreement with the obser-
vations of Shanmugarajan et al. (2008) regarding Ficus 
hispida; another very important plant of genus Ficus 
exhibited significant cardioprotective effect against 
cyclophosphamide provoked oxidative injury in rats. The 
significant reductions in the activities of CK-MB and LDH 
brought about by FRSACE-pretreatment could be due to 
the presence of racemosic acid (Li et al., 2004), quercetin 
(Khan & Sultana, 2005), gallic acid and ellagic acid (Rao 
et al., 2008), which are known to exhibit potent antioxi-
dant activity. The cardioprotective activity of Arjuna is 
very well established, wherein its protective effect is 
ascribed to the presence of various phenolics, tannins, 
glycosides, saponins, alkaloids, and flavonoids having 
potent antioxidant activity (Singh et al., 2008).
A significant increase (p ≤ 0.001) in the activities AST 
and ALT observed in the Dox group were effectively 
counteracted and restored toward normalization by 
FR
250
, FR
500
, and AR
100
 pretreatment. Although, FR
250
, 
FR
500
, and AR
100
 pretreatment did not decrease serum 
transaminase activities to control levels, they brought 
about 21%, 41%, and 23% reduction in the activity of 
AST and 44%, 65%, and 46% reduction in the activity of 
ALT, respectively. The results indicated that 500 mg kg−1 
dose of FRSACE offers optimal hepatoprotection. The 
hepatoprotective effect of FRSACE could conclusively be 
attributed to the presence of bergenin; an isocoumarin, 
since it is reported to exhibit significant hepatoprotec-
tive activity against CCl
4
-induced hepatotoxicity in rats 
(Lim et al., 2000).
Effect on oxidative stress
In states of oxidative stress, GSH is converted to gluta-
thione disulfide (GSSG) and depleted, leading to lipid 
peroxidation resulting in higher TBARS levels. Therefore, 
the role of GSH as a reasonable marker for the evalua-
tion of oxidative stress is important (Recknagel et al., 
1989). The FR
250
, FR
500
, and AR
100
 pretreatment signifi-
cantly decreased (p ≤ 0.05) lipid peroxidation induced by 
doxorubicin as reflected by lower TBARS and higher GSH 
values in heart and serum. The AR
100
 also decreased the 
oxidative stress significantly (p ≤ 0.05) and it was compa-
rable with that of FR
250
 (Figures 2 and 3). However, except 
FR
500
, none of the extracts resulted in complete reversal 
of the oxidative stress to normal levels. The complete 
reversal of the oxidative stress to normal levels by FR
500
 
could be attributed to various phenolic compounds and 
flavonoids such as quercetin, gallic acid, ellagic acid, and 
trepenoids; lupeol, lupeol acetate, and α-amyrin (Joy 
et al., 2001; Khan & Sultana, 2005; Rao et al., 2008) that 
are reported to act as strong antioxidant and anti-inflam-
matory agents (Khan & Sultana, 2005).
Figure 2. The TBARS levels in serum and heart. Data expressed as 
mean ± SD of n = 6 rats (p ≤ 0.05); FR
250
: FRSACE 250 mg kg−1, FR
500
: 
FRSACE 500 mg kg−1, AR
100
: Arjuna 100 mg kg−1, Dox: doxorubicin. 
Bars carrying different letters a, b, c differ significantly from each 
other (p ≤ 0.05).
Figure 3. Glutathione levels in serum and heart. Data expressed as 
mean ± SD of n = 6 rats (p ≤ 0.05); FR
250
: FRSACE 250 mg kg−1, FR
500
: 
FRSACE 500 mg kg−1, AR
100
: Arjuna 100 mg kg−1, Dox: doxorubicin. 
Bars carrying different letters a, b, c differ significantly from each 
other (p ≤ 0.05).
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Effect on histopathology of the heart
Dox administration exerted serious adverse effects on the 
cardiac muscle fibers. Perivascular mononuclear infil-
trate extending into the muscle fibers was seen in Dox-
treated group, suggesting inflammatory changes (Figure 
4A). Edema was also observed with separation of the car-
diac muscle fibers compared to control group wherein 
normal muscle fibers with vesicular nuclei were found 
(Figure 4B). In all the other groups (FR
250
, FR
500
, and AR
100
) 
the cardiac architecture was significantly restored toward 
normalization; however congested blood vessels associ-
ated with hemorrhages were seen in the sections of FR
250
 
and AR
100
 group (Figures 4C and D). In FR
500
, although 
no congested blood vessels and perivascular neutrophil 
infiltrate was seen, separation of cardiac muscle fibers 
was evident (Figure 4E).
conclusion
In conclusion, doxorubicin exposure results in pro-
nounced oxidative stress and administration of F. rac-
emosa stem bark extract protects the heart by scavenging 
free radicals. Although, the compounds responsible 
were traced from the HPLC fingerprinting and reported 
literature, there is need to isolate specific compound(s) 
for its optimal utilization as a therapeutic agent to derive 
maximum benefits of doxorubicin as an anticancer drug 
by reducing its toxic effects.
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Figure 4. (A) Section of the heart of Dox-treated rats showing inflammatory changes. (B) Section of the heart of control rats showing normal 
cardiac muscle fibers with vesicular nuclei. (C) Section of the heart of FRSACE (250 mg kg−1) + Dox-treated rats showing congested blood 
vessels and inflammatory changes. (D) Section of the heart of Arjuna (100 mg kg−1) + Dox-treated rats showing inflammatory changes. (E) 
Section of the heart of FRSACE (500 mg kg−1) + Dox-treated rats showing normal cardiac muscle fibers and some congested blood vessels; 
NMF: normal cardiac muscle fibers, PNMI: perivascular mononuclear infiltrate, CBV: congested blood vessel.
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